VGFC yields 3883.50% · JNJ yields 2.14%● Live data
📍 VGFC pulled ahead of the other in Year 1
Combined, VGFC + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VGFC + JNJ for your $10,000?
The Very Good Food Company Inc., together with its subsidiaries, designs, develops, produces, distributes, and sells various plant-based cheese, meats, and other food alternatives. The company offers its products through its wholesale and e-commerce stores, and public markets, as well as the Butcher Shop & Restaurant under The Very Good Butchers brand. The company provides plant-based cheese brands comprising Bold Cheddah, a white cheddar style vegan cheese; Cheedah, a medium cheddar style vegan cheese; Dill'ish, a garlic and dill-havarti style vegan cheese; Goud AF, a smoky gouda style vegan cheese; and Pepper Jack, a monterey jack style vegan cheese. It also offers plant-based meat products comprising a line of sausages, steaks, burgers, and meatballs that is gluten-free, soy-free, and Non-GMO verified under Butcher's Select and The Very Good Butchers brands. The company distributes and sells its products in 10 provinces and three territories in Canada and 50 states in the United States through eCommerce, wholesale, and company owned butcher shops and restaurants operated under Victoria Flagship Store name located in Victoria, Canada. The company was formerly known as The Very Good Butchers Inc. and changed its name to The Very Good Food Company Inc. in October 2019. The Very Good Food Company Inc. was incorporated in 2016 and is headquartered in Vancouver, Canada.
Full VGFC Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.